Protect Medication Abortion
Anti-abortion extremists are attacking medication abortion. Add your name in support of access to medication abortion.
Press Release
Reproductive Freedom for All Responds to Supreme Court Decision to Restore Access to Mifepristone
For Immediate Release: Thursday, May 14, 2026
Contact: [email protected]
Reproductive Freedom for All Responds to Supreme Court Decision to Restore Access to Mifepristone
Washington, DC — Today, the Supreme Court left its temporary stay in Louisiana v. FDA in place, preserving access to mifepristone for the time being while litigation continues at the lower court. Justices Alito and Thomas wrote separate dissents and relied on anti-abortion extremists’ arguments to assert Fifth Circuit’s order should go into effect.
Reproductive Freedom for All President and CEO Mini Timmaraju released the following statement:
“This case should never have made it to the Supreme Court in the first place. Mifepristone is safe, effective, and backed by decades of evidence, but anti-abortion extremists dragged this baseless case through the courts as part of their efforts to ban abortion nationwide. Today’s decision gives us temporary relief, but this is not the end of our fight. Anti-abortion extremists will keep using every tool available to push care out of reach in every state. This is exactly why the midterm elections are critical. We need leaders at every level of government to stop these attacks, protect reproductive freedom, and make sure people—not anti-abortion politicians or judges—can make their own healthcare decisions.”
Access to mifepristone will remain the same as it was before the Fifth Circuit’s ruling until the case is resolved at the lower courts. However, Trump and his allies have not slowed their attacks on medication abortion care access through other channels. In January, the Trump administration asked a federal court to pause Louisiana v. FDA until after the FDA completes its baseless, politically motivated “review” of mifepristone. Just this week, FDA Commissioner Martin Makary resigned after anti-abortion extremists met with the Trump administration and complained Makary had not done enough to restrict access to mifepristone. Their broader strategy is to weaponize HHS and the FDA to force politically motivated restrictions on mifepristone nationwide. The state politicians attacking medication abortion in courts and the Trump administration officials ordering a sham review of the FDA’s mifepristone regulations have the same agenda: to end abortion access nationwide.
###
For over 55 years, Reproductive Freedom for All (formerly NARAL Pro-Choice America) has fought to protect and advance reproductive freedom at the federal and state levels—including access to abortion care, birth control, pregnancy and post-partum care, and paid family leave—for everybody. Reproductive Freedom for All is powered by its more than 4 million members from every state and congressional district in the country, representing the 8 in 10 Americans who support legal abortion.
Press Release National